List of figures (European Drug Report 2025)
This page contains a full list of all figures and graphical elements available in the European Drug Report 2025 Note that, if viewing this page as part of a PDF, links will go to the online pages, not the corresponding figures in the PDF. Links are organised below according to the chapter in which they appear.
This page is part of the European Drug Report 2025, the EUDA's annual overview of the drug situation in Europe.
Last update: 5 June 2025
List of figures by chapter
- Understanding Europe’s drug situation in 2025 – key developments
- Drug supply, production and precursors
- Figure 1.1. Seizures of cocaine, amounting to 25 tonnes, made in the Port of Hamburg, April to September 2023
- Figure 1.2. Examples of drug trafficking methods previously reported by law enforcement in Europe
- Figure 1.3. Synthetic drug production facility dismantled by Netherlands Police, National Dismantling Facility (LFO), the Netherlands, 2024
- Figure 1.4. Precursor seizures in the European Union
- Figure 1.5. Drug seizures in the European Union – quantity of drugs seized, indexed trends (2013 = 100)
- Figure 1.6. Drug seizures in the European Union – number of reported drug seizures, breakdown by drug, 2023 (percent)
- Figure 1.7. Drug seizures in the European Union. (a) Number of seizures in 2023 and (b) Quantity seized in 2023 (tonnes)
- Figure 1.8. Drug seizures in the European Union – number of drug seizures, indexed trends (2013 = 100)
- Figure 1.9. Drug law offences – number of offences, supply and use/possession, 2023
- Figure 1.10. Drug law offences – possession/use offences, indexed trends (2013 = 100)
- Figure 1.11. Drug law offences – supply offences, indexed trends (2013 = 100)
- Figure 1.12. Illicit methadone production sites dismantled in Poland, August 2024
- Cannabis – the current situation in Europe
- Figure 2.1. Small-scale cannabis cultivation dismantled in Ireland in 2024
- Figure 2.2. Large cannabis cultivation site dismantled in Spain in 2024
- Figure 2.3. Shipment of 64 kilograms of herbal cannabis trafficked in checked luggage seized in Ireland in 2024
- Figure 2.4. Prevalence of cannabis use in Europe
- Figure 2.5. Cannabis residues in wastewater in selected European cities: changes between 2023 and 2024
- Figure 2.6. Users entering treatment for cannabis in Europe
- Figure 2.7a. Cannabis resin market in Europe
- Figure 2.7b. Herbal cannabis market in Europe
- Cocaine – the current situation in Europe
- Figure 3.1. Seizures of cocaine, amounting to 25 tonnes, made in the Port of Hamburg, April to September 2023
- Figure 3.2. Examples of drug trafficking methods previously reported by law enforcement in Europe
- Figure 3.3. Prevalence of cocaine use in Europe
- Figure 3.4. Cocaine residues in wastewater in selected European cities: changes between 2023 and 2024
- Figure 3.5. Cocaine users entering treatment
- Figure 3.6. Trends in the numbers of cocaine-related presentations in Euro-DEN Plus sentinel hospitals, 2022 to 2023
- Figure 3.7. Polysubstance toxicity in drug-induced death cases with cocaine involved, 2022, Spain
- Figure 3.8. Cocaine market in Europe
- Synthetic stimulants – the current situation in Europe
- Figure 4.1. Seizure of 546 kilograms of crystal methamphetamine, concealed in machinery in a shipping container being shipped from Ireland to Australia
- Figure 4.2. Part of a seizure of 800 kilograms of synthetic cathinones seized at a dismantled synthetic drug production laboratory in Lublin, Poland, 2024
- Figure 4.3. Prevalence of amphetamines use in Europe
- Figure 4.4. Amphetamine residues in wastewater in selected European cities: changes between 2023 and 2024
- Figure 4.5. Methamphetamine residues in wastewater in selected European cities: changes between 2023 and 2024
- Figure 4.6. Amphetamine users entering treatment in Europe
- Figure 4.7. Metamphetamine users entering treatment in Europe
- Figure 4.8. Synthetic cathinone users entering treatment in Europe
- Figure 4.9. Amphetamine market in Europe
- Figure 4.10. Methamphetamine market in Europe
- MDMA – the current situation in Europe
- Figure 5.1. MDMA production facilities dismantled by Belgian Police, in Limburg (left) and Liège (right), 2023
- Figure 5.2. Examples of risk alert communications issued at a music festival in Ireland, August 2024
- Figure 5.3. Prevalence of MDMA ('ecstasy') use in Europe
- Figure 5.4. MDMA residues in wastewater in selected European cities: changes between 2023 and 2024
- Figure 5.5. MDMA market in Europe
- Figure 5.6. Psychoactive adulterants detected in samples sold as MDMA to users and tested in 12 European drug checking services in 2024
- Figure 5.7. Purity of MDMA powder samples submitted to drug checking services in 2023 and 2024
- Figure 5.8. Content of MDMA tablet samples submitted to drug checking services in 2023 and 2024
- Heroin and other opioids – the current situation in Europe
- Figure 6.1. Age distribution of all clients entering treatment with heroin as their primary drug, 2013 and 2023
- Figure 6.2. Age distribution of never previously treated clients entering treatment with heroin as their primary drug, 2013 and 2023
- Figure 6.3. Trends in the main route of administration of clients entering treatment with heroin as primary drug, by treatment status
- Figure 6.4. A consignment of 60 kilograms of heroin trafficked through the Netherlands and France on a Cessna 210 light aircraft to Weston Airport, Dublin, Ireland, December 2023
- Figure 6.5. Seizure of 436 kilograms of heroin concealed in cable machines, Port of Burgas, Bulgaria
- Figure 6.6. Users entering treatment for heroin in Europe
- Figure 6.7a. Proportion of acute drug toxicity presentations with mention of heroin in Euro-DEN Plus hospitals, 2023
- Figure 6.7b. Trends in the proportion of presentations with mention of heroin in 2016-2023, in selected Euro-DEN Plus hospitals
- Figure 6.8. Heroin market in Europe
- New psychoactive substances – the current situation in Europe
- Figure 7.1. Seized warehouse and laboratory producing synthetic cannabinoids in Greece, 2023
- Table 7.2. Semi-synthetic cannabinoids production facility dismantled in 2023 by Romanian police
- Figure 7.3. Part of a seizure of 800 kilograms of synthetic cathinones seized at a dismantled synthetic drug production laboratory in Lublin, Poland, 2024
- Figure 7.4. Fake oxycodone tablets containing metonitazene, seized in Sweden in 2023
- Figure 7.5. Number of new psychoactive substances reported for the first time to the EU Early Warning System, by category, 2005-2024
- Figure 7.6. Number of new psychoactive substances reported each year following their first identification in the European Union, by category, 2005-2023
- Figure 7.7. Number of new opioids reported for the first time to the EU Early Warning System, 2009-2024
- Figure 7.8a. Seizures of new psychoactive substances in the European Union: number of seizures, 2006-2023
- Figure 7.8b. Seizures of new psychoactive substances in the European Union: quantity seized, 2006-2023
- Figure 7.9. Seizures of new psychoactive substances in the European Union: percentage of total quantity seized, by substance, 2023
- Other drugs – the current situation in Europe
- Figure 8.1. Fake benzodiazepine tablets containing nitazene opioids from risk alert issued by Ireland’s Health Service Executive, June 2024
- Figure 8.2. Number of formal notifications of benzodiazepines reported to the EU Early Warning System, 2005-2023
- Table 8.3. Ketamine residues in wastewater in selected European cities: changes between 2023 and 2024
- Table 8.4. Proportion of acute drug toxicity presentations with mention of GHB/GBL, Euro-DEN Plus sentinel hospitals, 2023
- Figure 8.5. Seizures of ketamine powder in the European Union: total quantity (kilograms), 2006-2023
- Figure 8.6. SSeizures of ketamine powder in the European Union: total number, 2006-2023
- Injecting drug use in Europe – the current situation
- Figure 9.1a. Estimated prevalence of people who inject drugs in the last 12 months (per 1000 population), 2023 or latest data
- Figure 9.1b. Estimated number of people who inject drugs in the last 12 months, by country, 2023 or latest data
- Figure 9.2. Trends in injecting among first-time treatment entrants with heroin, cocaine, amphetamine or methamphetamine as primary drug: percentage reporting injecting as main route of administration
- Figure 9.3. Percentage of used syringes tested positive by drug category, by city, 2023
- Drug-related infectious diseases – the current situation in Europe
- Figure 10.1. New HIV notifications linked to injecting drug use in the European Union, 2009 to 2023
- Figure 10.2. Number of sterile syringes distributed per person who injects drugs per year, 2023 or latest data
- Figure 10.3. Availability of needle syringe programmes in Europe at regional level, 2023 or the most recent year available
- Figure 10.4. Most-recent documented HIV outbreaks in EUDA member states among people who inject drugs: number of HIV cases and the associated injected substance, 2014 to 2023
- Figure 10.5. Drug-related infectious diseases
- Drug-induced deaths – the current situation in Europe
- Figure 11.1. Distribution of the cases with heroin mentioned in Austria, Slovenia and Norway in 2023
- Figure 11.2. Interventions to prevent opioid-related deaths, by intended aim and evidence of benefit
- Figure 11.3. Proportion of males among drug-induced deaths in the European Union, Norway and Türkiye in 2023, or most recent year (percent)
- Figure 11.4. Number of drug-induced deaths reported in the European Union in 2013 and 2023, or the most recent year, by age band
- Figure 11.5a. Drug-induced deaths
- Figure 11.5b. Drug-induced deaths in the European Union: age at death, 2023 or most recent available data (percent)
- Figure 11.5c. Trends in drug-induced deaths in the European Union, Norway and Türkiye
- Figure 11.5d. Age distribution (percent) of drug-induced deaths reported in the European Union, Norway and Türkiye in 2023 or the most recent year
- Figure 11.6. Proportion of drug-induced deaths with opioids mentioned, 2023 or most recent available data
- Figure 11.7. Proportion of drug-induced deaths with mention of alcohol and benzodiazepines
- Opioid agonist treatment – the current situation in Europe
- Harm reduction – the current situation in Europe
- Figure 13.1. Number of European countries implementing selected harm reduction interventions, up to 2024
- Figure 13.2. Interventions to prevent opioid-related deaths, by intended aim and evidence of benefit
- Figure 13.3. Example of a rapid risk communication issued in Ireland, 2024
- Figure 13.4. Needle and syringe distribution and opioid agonist treatment coverage in relation to WHO 2025 targets, 2023 or latest available estimate
- Figure 13.5. Availability of take-home naloxone, available formulations, number of persons trained and number of kits given out, in Europe
- Figure 13.6. An illustration of the range of drug checking technologies available and their relative accuracy and reliability
- Figure 13.7. Location and number of drug consumption facilities throughout Europe, 2023
- Figure 13.8. Availability of drug-related and other health and social care interventions targeting people who use drugs and are in prison, Europe, 2023